Literature DB >> 15226858

Plasma malondialdehyde in coronary patients and in "normal" people at rest and after exercise.

P Avogaro1, G B Bon, G Cazzolato, G Gualandi, G Caturelli.   

Abstract

The behavior of plasma lipid peroxides, expressed as plasma malondialdehyde, was studied in 27 patients with documented coronary artery disease and 17 volunteers without coronary artery disease (henceforth designated "normal"), after a standardized exercise on a bicycle ergometer. In the control group, the basal values of malondialdehyde were significantly lower than in coronary patients. Persons in the control group did not show any significant variation of malondialdehyde after exercise and recovery, whereas patients with coronary artery disease showed malondialdehyde levels significantly higher than the baseline, both after exercise and after recovery. In the control group, a significant inverse correlation between the malondialdehyde variations during the exercise and the total work produced was ten times lower than in coronary patients. It seems probable that the higher levels of lipid peroxides in these patients may leave some long-term unwanted effects. Furthermore, the increased values of lipid peroxides after exercise may be regarded as a possible trigger of fatal myocardial malfunction occurring during physical activity.

Entities:  

Year:  1986        PMID: 15226858      PMCID: PMC351723     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  13 in total

1.  Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta.

Authors:  J GLAVIND; S HARTMANN; J CLEMMESEN; K E JESSEN; H DAM
Journal:  Acta Pathol Microbiol Scand       Date:  1952

2.  The "stone heart" and other challenges to the biochemist.

Authors:  A M Katz; M Tada
Journal:  Am J Cardiol       Date:  1977-06       Impact factor: 2.778

3.  An approach to free radicals.

Authors:  T L Dormandy
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

Review 4.  Biology of disease: free radicals and tissue injury.

Authors:  B A Freeman; J D Crapo
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

Review 5.  Oxygen toxicity, oxygen radicals, transition metals and disease.

Authors:  B Halliwell; J M Gutteridge
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

6.  Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations.

Authors:  G G Neri Serneri; G F Gensini; R Abbate; C Mugnaini; S Favilla; C Brunelli; S Chierchia; O Parodi
Journal:  Am Heart J       Date:  1981-02       Impact factor: 4.749

7.  Accurate detection of coronary heart disease by new exercise test.

Authors:  M S Elamin; R Boyle; M M Kardash; D R Smith; J B Stoker; W Whitaker; D A Mary; R J Linden
Journal:  Br Heart J       Date:  1982-10

8.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.

Authors:  M Hamberg; J Svensson; T Wakabayashi; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

9.  Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.

Authors:  D W Morel; J R Hessler; G M Chisolm
Journal:  J Lipid Res       Date:  1983-08       Impact factor: 5.922

10.  Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides.

Authors:  W A Pryor; J P Stanley; E Blair
Journal:  Lipids       Date:  1976-05       Impact factor: 1.880

View more
  1 in total

1.  Three months of moderate-intensity exercise reduced plasma 3-nitrotyrosine in rheumatoid arthritis patients.

Authors:  Alex J Wadley; Jet J C S Veldhuijzen van Zanten; Antonios Stavropoulos-Kalinoglou; George S Metsios; Jacqueline P Smith; George D Kitas; Sarah Aldred
Journal:  Eur J Appl Physiol       Date:  2014-04-10       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.